Denali Therapeutics shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Denali Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Denali Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Denali Therapeutics by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $31M | 2.2M | 14.52 |
| 2025-03-31 | $23M | 1.7M | 13.60 |
| 2024-12-31 | $22M | 1.1M | 20.38 |
| 2024-09-30 | $40M | 1.4M | 29.13 |
| 2024-06-30 | $28M | 1.2M | 23.22 |
| 2024-03-31 | $19M | 904k | 20.52 |
| 2023-12-31 | $8.5M | 394k | 21.46 |
| 2023-09-30 | $8.4M | 407k | 20.63 |
| 2023-06-30 | $19M | 645k | 29.51 |
| 2023-03-31 | $13M | 573k | 23.04 |
| 2022-12-31 | $22M | 772k | 27.81 |
| 2022-06-30 | $12M | 421k | 29.43 |
| 2022-03-31 | $13M | 406k | 32.17 |
| 2021-12-31 | $18M | 411k | 44.60 |
| 2021-09-30 | $53M | 1.1M | 50.45 |
| 2021-03-31 | $37M | 648k | 57.10 |
| 2020-12-31 | $59M | 702k | 83.76 |
| 2020-09-30 | $18M | 506k | 35.83 |
| 2020-06-30 | $5.5M | 228k | 24.18 |
| 2019-12-31 | $1.8M | 101k | 17.43 |
| 2019-09-30 | $1.6M | 104k | 15.32 |
| 2019-06-30 | $2.0M | 96k | 20.76 |
| 2019-03-31 | $2.5M | 107k | 23.22 |
| 2018-12-31 | $1.4M | 68k | 20.67 |
| 2018-09-30 | $265k | 12k | 21.76 |
| 2018-06-30 | $816k | 54k | 15.24 |
| 2018-03-31 | $2.6M | 133k | 19.69 |
| 2017-12-31 | $2.2M | 140k | 15.64 |